XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   33,499,953      
Beginning balance at Dec. 31, 2020 $ 210,918 $ 3 $ 364,248 $ 599 $ (153,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of options (in shares)   101,947      
Common stock issued upon exercise of options 859   859    
Issuance of common stock for vesting of restricted stock units (in shares)   365,747      
Shares repurchased for withholding tax on restricted stock units (in shares)   (146,660)      
Shares repurchased for withholding tax on restricted stock units (8,821)   (8,821)    
Issuance of common stock under cashless warrant exercise (in shares)   341,262      
Issuance of common stock under investor warrant exercise (in shares)   1,351,530      
Issuance of common stock under investor warrant exercise 22,787   22,787    
Issuance of common stock in connection with follow-on public offering, net of offering costs (in shares)   5,526,861      
Issuance of common stock in connection with follow-on public offering, net of offering costs 309,782 $ 1 309,781    
Issuance of common stock in connection with business combination (in shares)   255,945      
Issuance of common stock in connection with business combination 16,736   16,736    
Stock-based compensation expense 2,100   2,100    
Net (loss) income 7,197       7,197
Foreign currency translation (loss) gain 603     603  
Ending balance (in shares) at Jun. 30, 2021   41,296,585      
Ending balance at Jun. 30, 2021 562,161 $ 4 707,690 1,202 (146,735)
Beginning balance (in shares) at Mar. 31, 2021   33,970,364      
Beginning balance at Mar. 31, 2021 211,848 $ 3 360,015 822 (148,992)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of options (in shares)   69,675      
Common stock issued upon exercise of options 587   587    
Issuance of common stock for vesting of restricted stock units (in shares)   151,423      
Shares repurchased for withholding tax on restricted stock units (in shares)   (58,300)      
Shares repurchased for withholding tax on restricted stock units (3,315)   (3,315)    
Issuance of common stock under cashless warrant exercise (in shares)   29,087      
Issuance of common stock under investor warrant exercise (in shares)   1,351,530      
Issuance of common stock under investor warrant exercise 22,787   22,787    
Issuance of common stock in connection with follow-on public offering, net of offering costs (in shares)   5,526,861      
Issuance of common stock in connection with follow-on public offering, net of offering costs 309,782 $ 1 309,781    
Issuance of common stock in connection with business combination (in shares)   255,945      
Issuance of common stock in connection with business combination 16,736   16,736    
Stock-based compensation expense 1,099   1,099    
Net (loss) income 2,257       2,257
Foreign currency translation (loss) gain 380     380  
Ending balance (in shares) at Jun. 30, 2021   41,296,585      
Ending balance at Jun. 30, 2021 $ 562,161 $ 4 707,690 1,202 (146,735)
Beginning balance (in shares) at Dec. 31, 2021 44,618,357 44,618,357      
Beginning balance at Dec. 31, 2021 $ 635,180 $ 4 777,074 (1,382) (140,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of options (in shares) 8,283 8,283      
Common stock issued upon exercise of options $ 75   75    
Issuance of common stock for vesting of restricted stock units (in shares)   540,178      
Shares repurchased for withholding tax on restricted stock units (in shares)   (155,265)      
Shares repurchased for withholding tax on restricted stock units (2,219)   (2,219)    
Issuance of common stock under cashless warrant exercise (in shares)   99      
Stock-based compensation expense 4,981   4,981    
Net (loss) income (226,608)       (226,608)
Foreign currency translation (loss) gain $ (2,171)     (2,171)  
Ending balance (in shares) at Jun. 30, 2022 45,011,652 45,011,652      
Ending balance at Jun. 30, 2022 $ 409,238 $ 4 779,911 (3,553) (367,124)
Beginning balance (in shares) at Mar. 31, 2022   44,822,866      
Beginning balance at Mar. 31, 2022 615,457 $ 4 778,463 802 (163,812)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of options (in shares)   518      
Common stock issued upon exercise of options 5   5    
Issuance of common stock for vesting of restricted stock units (in shares)   262,176      
Shares repurchased for withholding tax on restricted stock units (in shares)   (73,908)      
Shares repurchased for withholding tax on restricted stock units (630)   (630)    
Stock-based compensation expense 2,073   2,073    
Net (loss) income (203,312)       (203,312)
Foreign currency translation (loss) gain $ (4,355)     (4,355)  
Ending balance (in shares) at Jun. 30, 2022 45,011,652 45,011,652      
Ending balance at Jun. 30, 2022 $ 409,238 $ 4 $ 779,911 $ (3,553) $ (367,124)